Comparative Study of Efficacy and Adverse Effects of Ginger Extract and Loratadine for Treatment of Allergic Rhinitis Patients (Clinical Trial Phase II)
Phase 2
Completed
- Conditions
- Rhinitis is broadly defined as inflammation of the nasal mucosa. It is a common disorder that affects up to 40% of the population.
- Registration Number
- TCTR20151001001
- Lead Sponsor
- Thai Traditional Medical Knowledge Fund
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
1.Patients have moderate allergic rhinitis (itching and nasal obstruction,watery nasal discharge,sneezing and congestion )with a minimum total nasal symptom score 5 point
2.These patients do not have respiratory disease such as tuberculosis, nasal polyps.
3.These patients do not have history of disease: heart disease, kidney disease, liver disease, epilepsy, high blood pressure and severe asthma.
4.These patients are not pregnanct or breastfeeding.
5.These patients have normal BMI and vital signs.
Exclusion Criteria
1.Those who have taken anti-coagulant and anti-platelet aggregation medications.
2.Those who get serious side effects from Loratadine and ginger allergy.
3.Communication problems especially listening and interview.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method nasal symptom 42 days total nasal symptom score ,nasal patency 42 days Acoustic rhinometry
- Secondary Outcome Measures
Name Time Method Quality of Life 3 weeks Rhinoconjunctivitis Quality of Life Questionnaire